PCN32 COMPARATIVE EFFICACY OF PEMBROLIZUMAB PLUS AXITINIB (P+A) VERSUS FIRST-LINE SYSTEMIC THERAPIES FOR ELDERLY PATIENTS WITH ADVANCED/METASTATIC RCC (MRCC): A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS

Category Systematic review
JournalValue in Health
Year 2019
This article has no abstract
Epistemonikos ID: fa3f1ef55b5cdaf885cddb5c8d33dcaa98c93cd1
First added on: Feb 11, 2025